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Abstract
Background: Due to lack of efficacy in recent trials, current guidelines for the treatment of neurally-mediated (vasovagal)
syncope do not promote cardiac pacemaker implantation. However, the finding of asystole during head-up tilt –induced
(pre)syncope may lead to excessive cardioinhibitory syncope diagnosis and treatment with cardiac pacemakers as blood
pressure is often discontinuously measured. Furthermore, physicians may be more inclined to implant cardiac pacemakers
in older patients. We hypothesized that true cardioinhibitory syncope in which the decrease in heart rate precedes the fall in
blood pressure is a very rare finding which might explain the lack of efficacy of pacemakers in neurally-mediated syncope.
Methods: We studied 173 consecutive patients referred for unexplained syncope (114 women, 59 men, 4261 years, 1762
syncopal episodes). All had experienced (pre)syncope during head-up tilt testing followed by additional lower body
negative suction. We classified hemodynamic responses according to the modified Vasovagal Syncope International Study
(VASIS) classification as mixed response (VASIS I), cardioinhibitory without (VASIS IIa) or with asystole (VASIS IIb), and
vasodepressor (VASIS III). Then, we defined the exact temporal relationship between hypotension and bradycardia to
identify patients with true cardioinhibitory syncope.
Results: Of the (pre)syncopal events during tilt testing, 63% were classified as VASIS I, 6% as VASIS IIb, 2% as VASIS IIa, and
29% as VASIS III. Cardioinhibitory responses (VASIS class II) progressively decreased from the youngest to the oldest age
quartile. With more detailed temporal analysis, blood pressure reduction preceded the heart-rate decrease in all but six
individuals (97%) overall and in 10 out of 11 patients with asystole (VASIS IIb).
Conclusions: Hypotension precedes bradycardia onset during head-up tilt-induced (pre)syncope in the vast majority of
patients, even in those classified as cardioinhibitory syncope according to the modified VASIS classification. Furthermore,
cardioinhibitory syncope becomes less frequent with increasing age.
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Introduction
Neurally-mediated (vasovagal) syncope is common in all age
groups [1–3]. Patients with frequent syncope have a markedly
reduced quality of life, similar to that of patients with severe
rheumatoid arthritis or chronic low back pain [4]. Neurally-
mediated syncope is induced by sudden vasodilation due to
sympathetic nervous system withdrawal with or without vagally-
mediated bradycardia or frank asystole. The cause is unknown [5].
Treatment options for highly symptomatic patients not responding
to volume loading and physical countermeasures [6,7] are limited
[2]. Almost 100 years ago, Sir Thomas Lewis commented:
‘‘Undoubtedly the main cause lies in the blood vessels. Atropine,
while raising heart rate leaves the blood pressure below normal
and the patient still pale and not fully conscious […]’’ [8]. Indeed,
prevention of bradycardia and asystole with cardiac pacemakers
was largely ineffective [9,10] and is only recommended when
severe spontaneous bradycardia is detected during prolonged
EKG monitoring, but not on tilt test results alone [11].
Nevertheless, pacemaker treatment is still being investigated in
patients with high probability of cardioinhibitory syncope [12] and
in our experience a significant proportion of syncope patients
undergo cardiac pacemaker implantation outside of clinical trials.
Furthermore, the increasing use of implantable EKG loop
recorders and head-up tilt testing without continuous measure-
ment of blood pressure may lead to excessive cardioinhibitory
syncope diagnosis and treatment. We hypothesized that true
cardioinhibitory syncope in which the decrease in heart rate
coincides or precedes the fall in blood pressure is rare which would
in part explain the lack of efficacy of cardiac pacing in neurally-
mediated syncope. We therefore analyzed heart rate and blood
pressure responses during head-up tilt induced (pre)syncope to
define the temporal relationship between hypotension and
bradycardia or asystole and to identify patients with true
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cardioinhibitory syncope. We were particularly interested in
influences of age on these responses because physicians may be
more inclined to implant cardiac pacemakers in older patients.
Methods
Ethics statement
We conducted a retrospective analysis of data acquired during
routine diagnostic work-up in patients with unexplained syncope.
Thus, patients did not undergo experimental diagnostic tests or
treatments, which would require obtaining a separate informed
consent. The analysis of data is covered by the general contract
governing medical treatment of the Medical University Charite´
which all patients signed and agreed on. The institutional ethics
committee of the Medical University Charite´ approved the study
analysis and publication of anonymous data.
Patients
We retrospectively analyzed data of 173 consecutive patients
(114 women, 59 men) who were referred to the Autonomic
Dysfunction Laboratory of the Medical University Charite´ for
head-up tilt testing as part of the routine diagnostic work-up for
unexplained syncope. Only patients who experienced neurally-
mediated (pre)syncope during head-up tilt were included in the
analysis. Patients (n = 132) either received no current medications
or their medications were discontinued at least 5 half-lives before
testing. In 41 patients, medication had not been fully discontinued.
Head-up tilt protocol
Head-up tilt testing began in the morning in the majority of
patients (median 10:06 a.m., range 08:43 a.m.–15:21 p.m.). For
baseline recordings, patients rested supine in a quiet laboratory at
an ambient temperature of 22–23uC. After a stable baseline was
achieved, patients were passively tilted to 60u head-up tilt. After
20 min and while still at 60u head-up tilt, lower body negative
pressure of 220 mmHg was applied for 10 min, followed by
another 10 min at 240 mmHg (Leeds protocol [13]). The tilt test
was aborted when finger blood pressure and/or heart rate
decreased below baseline values and patients reported symptoms
of imminent syncope, such as nausea, dizziness, warmth, visual or
hearing difficulties. Throughout the test, heart rate was electro-
cardiographically monitored (Cardioscreen, Medis, Germany).
Brachial blood pressure was measured every 2 min with an
automated oscillometric device (Dinamap, Critikon, USA). Beat-
to-beat blood pressure was continuously monitored by a finger
servo-plethysmomanometer (2300 Finapres, Ohmeda, USA) that
was kept at heart level throughout the tilt study.
Data acquisition and analysis
Electrocardiogram, finger blood pressure and thoracic imped-
ance signals were analog to digital converted at 500 Hz using the
Windaq pro+ software (Dataq Instruments Inc., USA). RR
intervals (time between subsequent R waves in the EKG) and
blood pressure were defined off-line using a program written by
Andre´ Diedrich based on PV-wave software (Visual Numerics
Inc., USA). The onset of the decrease in blood pressure and – if
present – heart rate was identified manually from beat-to-beat
recordings (see Figure 1 for examples). Accordingly, blood pressure
and heart rate before the onset of (pre)syncope and immediately
before termination of the head-up tilt test were determined from
beat-to-beat recordings (10 sec mean values). Hemodynamic
patterns during (pre)syncope were analyzed according to the
modified Vasovagal Syncope International Study (VASIS) classi-
fication [14,15] (Table 1). Furthermore, we calculated the
respective slopes of the decrease in blood pressure (and heart
rate, if present) by dividing the absolute amount of decrease by the
time between the onset of the decrease and the end of head-up tilt.
Orthostatic tolerance was assessed as the time from the beginning
of head-up tilt to tilt-induced (pre)syncope. The percentage of
differences between successive RR intervals greater than 50 ms
(pnn50) as a standard index of vagal modulation of heart rate [16]
was analyzed from 5 min EKG recordings in the supine position.
Patients with atrial fibrillation or multiple atrial or ventricular
premature beats were excluded from this analysis.
Statistics
All data is expressed as mean6SEM. We compared variances
between the groups by using the F test. Differences in parametric
data were compared by unpaired t test. Nonparametric data was
analyzed by Mann-Whitney U test. For multiple comparisons of
continuous data between age quartiles, one-way ANOVA and
Bonferroni post-test were applied. Distribution of VASIS classes
between groups was analyzed by chi square test. A value for p,.05
was considered significant. All calculations were done with Prism
5.01 (GraphPad Software Inc., USA).
Results
Mean age was similar in male and female syncope patients
(4562 vs. 4162 years, ns). Women reported more syncopal
episodes (2063 vs. 1163, p,.05 over a longer duration than men
(1161 vs. 661 years, p,.05), indicating an earlier onset of
syncope in women. However, the frequency of syncopal spells was
similar in women and in men. Cardiovagal tone assessed by heart
rate variability was not different between sexes, but women had
lower blood pressure and higher heart rates than men, both in the
supine position and throughout head-up tilt. However, orthostatic
tolerance did not differ between sexes (women: 1670639 sec,
men: 1711670 sec, ns) nor between age quartiles (Table 2).
The most common hemodynamic pattern upon tilt-induced
(pre)syncope was a mixed response (VASIS class I, 63%), followed
by the vasodepressor type (VASIS class III, 29%). Cardioinhib-
itory with (VASIS IIb, 6%) or without asystole (VASIS IIa, 2%)
were much rarer. Interestingly, the onset of hypotension
(11666 sec before (pre)syncope) preceded the onset of bradycardia
(4765 sec) in all but six individuals (97%, Figure 2), irrespective of
age. This observation held true for all VASIS groups: even of the
eleven patients who presented a cardioinhibitory response with
asystole (VASIS IIb) during head-up tilt, the decrease in blood
pressure preceded the decrease in heart rate in all but one (91%,
Figures 3 and 1, Panel D). Mean duration of asystole was
12.362.2 sec (range: 4.4–26.8 sec). Noteworthy, recovery from
asystole was spontaneous in all cases, with no other intervention
than resuming the supine position.
Clinical data of age quartiles is summarized in Table 3. When
stratified for age, the oldest quartile had a lower heart rate in the
supine position, but blood pressure did not differ between age
quartiles (Table 2). Cardiac vagal tone at rest was successively
decreased with increasing age.
With head-up tilt, the increase in heart rate was blunted with age
(Figure 4, upper panel). Overall tilt time did not differ between age
quartiles. In regard to VASIS classes, cardioinhibitory responses
were significantly more frequent with younger age (14% in the
youngest quartile compared to 0% in the oldest quartile, p,.05,
Table 4 and Figure 5), while vasodepressor responses prevailed with
higher age (50% in the oldest quartile compared with 23% in the
youngest quartile, p,.01). However, the onset of the decrease in
blood pressure and – if present – heart rate upon (pre)syncope came
Neurally-Mediated Syncope
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successively earlier with increasing age (Figure 4). Conversely, both,
the absolute decreases in blood pressure and heart rate and the
slopes of decreases in blood pressure and heart rate were
progressively blunted with increasing age. However, absolute values
for heart rate and blood pressure immediately at (pre)syncope were
not different between age quartiles.
Discussion
The main finding of our study is that hypotension precedes
bradycardia onset during head-up tilt-induced (pre)syncope in the
vast majority of patients. The finding is in accordance with earlier
studies [17,18]. Moreover, we observed that blood pressure
Table 1. Modified VASIS classification [15].
Class Description Definition
I mixed Decrease in heart rate .10%, minimal heart rate .40 bpm or less than 40 bpm for less than 10 sec
with or without asystole of less than 3 sec.
Blood pressure falls before heart rate.
IIa cardioinhibitory without asystole Minimal heart rate ,40 bpm for .10 sec, but asystole of more than 3 sec does not occur.
Blood pressure falls before heart rate.
IIb cardioinhibitory with asystole Asystole occurs for more than 3 sec.
Heart rate coincides with or precedes blood pressure fall.
III vasodepressor Decrease in heart rate ,10% of maximal heart rate.
doi:10.1371/journal.pone.0026489.t001
Figure 1. Original tracings of blood pressure (upper tracings) and heart rate (lower tracings) in four representative individuals who
experienced a cardioinhibitory response with asystole (VASIS class IIb) during head-up tilt. Black and white arrows indicate the onset of
hypotension and bradycardia, respectively. Hypotension preceded the onset of bradycardia in most (Panels A–C) but not all patients (Panel D). Panel
A: female, 33 years; panel B: female, 52 years; panel C: female 17 years; panel D: female, 32 years.
doi:10.1371/journal.pone.0026489.g001
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reduction precedes bradycardia onset even in patients with a
cardioinhibitory response according to the modified VASIS
classification. Mean blood pressure and heart rate during
(pre)syncope were almost identical among age quartiles. Yet, we
observed a gradual decline in the proportion of patients with
asystole during tilt testing with increasing age.
We applied head-up tilt testing combined with lower body
negative pressure to induce neurally-mediated (pre)syncope under
laboratory conditions. Compared with standard head-up tilt
testing, the methodology may provide a more reproducible
measure of orthostatic tolerance [19]. We cannot rule out that
the hemodynamic response during head-up tilt testing may differ
from the hemodynamic response during spontaneous syncope. A
loop electrocardiogram recorder study suggested that the (pre)-
syncope mechanism during head-up tilt does not correlate well
with electrocardiographic findings during an ambulatory episode
[20]. In fact, there is conflicting data about the reproducibility of
the VASIS type with repeated head-up tilt, which has been
reported between 14 and 83% [21–24]. Nevertheless, our findings
on the physiological phenomenology of neurally-mediated syncope
support the notion that the diagnosis of cardioinhibitory type
syncope during head-up tilt testing should be scrutinized. In
accordance with recent guidelines [11] our findings indicate that
head-up tilt test induced cardioinhibition should not be used as
indication for cardiac pacemaker implantation.
Occurrence of asystole is disquieting. However, asystole in the
setting of neurally-mediated syncope occurs in 1.3–5.1% of adult
patients [25–28] and up to 10% in children [19]. Yet, mortality of
patients with neurally-mediated syncope is not elevated compared
to healthy individuals without syncope [29]. Furthermore, asystole
Table 2. Clinical data of patients - age quartiles.
1. Quartile 2. Quartile 3.Quartile 4. Quartile
n =43 n=44 n=44 n=42
Unit Mean±SEM Mean±SEM Mean±SEM Mean±SEM p
Female gender [n (%)] 32 (74%) 27 (61%) 29 (66%) 26 (62%) ns
Age [years] 1961 3561 5161 6661 ,.001
Age range [years] 12–24 25–42 43–57 58–79 n/a
Height [cm] 17061 17461 16961 16761 ,.01
Weight [kg] 6562 7662 7762 7362 ,.001
Body mass index [kg/m2] 22.260.5 25.260.5 26.660.6 26.060.5 ,.001
Number of syncopal episodes 1865 1262 2766 1263 ,.05
Duration of syncope history [years] 461 1062 1262 962 ,.05
Time to (pre)syncope during HUT [sec] 1647671 1723663 1706683 1658662 ns
Clinical characteristics of patients separated into age quartiles. Statistical significance between groups was tested by chi square test for categorical data (gender) or
ANOVA for multiple comparisons with Bonferroni post test (all other parameters). HUT= head-up tilt.
doi:10.1371/journal.pone.0026489.t002
Figure 2. Individual data and mean±SEM in the difference between the onset of hypotension and the onset of bradycardia
stratified for age quartiles. Hypotension preceded the decrease in heart rate in all but six individuals (97%) irrespective of age.
doi:10.1371/journal.pone.0026489.g002
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during head-up tilt testing does not herald poor outcome in
patients with neurally-mediated syncope [27]. Finally, sinus and
atrioventricular node function is not impaired in syncope patients
who presented with a cardioinhibitory response during head-up tilt
compared to those patients of other VASIS classes [30].
Whether or not cardiac pacing may have utility in the treatment
of neurally-mediated syncope is still debated. While Sir Thomas
Lewis was convinced that vasodilatation and the resulting decrease
in peripheral resistance were the prevailing mechanisms [8], recent
studies yielded more complex and sometimes conflicting results.
Muscle sympathetic activity as a measure of sympathetic
vasomotor tone was maintained during tilt-induced (pre)syncope
in a patient subset [31]. Furthermore, indirect measurements were
consistent with cardiac output reductions during tilt-induced
(pre)syncope [32]. Whatever the exact contributions of cardiac
output and peripheral resistance to the decrease in blood pressure
upon neurally-mediated syncope might be, cardiac pacing
counteracts the bradycardia but cannot ameliorate vasodilation.
Indeed, cardiac pacing was not effective in neurally-mediated
(pre)syncope prevention [18]: while some earlier open-label studies
were positive [33–35], methodically more sound recent studies
were negative [9,10]. To date, an additional study is still ongoing
[12].
In our study, hypotension preceded bradycardia onset in the
vast majority of patients including those who presented a
cardioinhibitory response with asystole for more than 3 sec. The
finding challenges the modified VASIS classification which
postulates that in cardioinhibitory syncope with asystole of more
than 3 sec the fall in heart rate ‘‘coincides with or precedes’’ the
fall in blood pressure [15]. In our study head-up tilt testing was
aborted when the decrease in blood pressure became symptom-
atic. We did not prolong head-up tilt testing until each subject
became fully unconscious as it has been proposed by others [15].
Thus, we might have missed some cases of asystole which could
have occurred later on. However, we were nevertheless able to
observe sequence of the hemodynamic reaction early during
(pre)syncope. Furthermore, prolonging head-up tilt could increase
the proportion of false-positive cardioinhibitory syncope classifi-
cations.
Traditionally, neurally-mediated syncope was considered to
primarily affect young people. Recently [3], this notion has been
softened possibly due to the increasing use of head-up tilt testing as
a diagnostic tool. In 352 patients with unexplained syncope,
positive head-up tilt tests occurred in 58% of patients ,65 years,
but still in 37% and 20% of patients .65 years and .80 years,
respectively, with no difference in time to (pre)syncope [36]. In
another study in 590 patients with transient loss of consciousness,
neurally-mediated syncope was more frequent in younger patients,
but still presented the most frequent single cause for syncope even
in the oldest group of patients [3]. Other large studies in patients
with recurrent syncope found no difference in the rates of positive
Figure 3. Individual data and mean±SEM in the difference
between the onset of hypotension and the onset of bradycar-
dia for those patients who experienced asystole during head-
up tilt (VASIS class IIb). Hypotension preceded the decrease in heart
rate in all but one individual (91%).
doi:10.1371/journal.pone.0026489.g003
Table 3. Clinical data of patients.
All
n =173
Unit Mean±SEM Range
Female gender [n (%)] 114 (66%) n/a
Age [years] 4261 12–79
Height [cm] 17061 150–194
Weight [kg] 7361 46–115
Body mass index [kg/m2] 25.060.3 17.3–35.8
Number of syncopal episodes 1762 1–120
Duration of syncope history [years] 961 0.1–58
Time to (pre)syncope during HUT [sec] 1684635 141–2603
HUT= head-up tilt.
doi:10.1371/journal.pone.0026489.t003
Figure 4. Mean values of heart rate (upper panel) and mean
blood pressure (lower panel) at 5 sec intervals in the supine
position, during early head-up tilt (HUT), and during tilt-
induced (pre)syncope stratified for age (green: 1st quartile, 12–
24 years, n =26; blue: 2nd quartile, 25–42 years, n =27; violet:
3rd quartile, 43–57 years, n =36; red: 4th quartile, 58–79 years,
n =20). The vertical lines indicate the onset of decreases in heart rate
and blood pressure, respectively. Younger patients had a larger increase
in heart rate with head-up tilt. However, the onset of hemodynamic
events began earlier with increasing age. Furthermore, the decrease in
heart rate upon tilt-induced (pre)syncope was progressively blunted
with increasing age.
doi:10.1371/journal.pone.0026489.g004
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test results between age groups [25,37]. In accordance with our
findings, the percentage of vasodepressor (VASIS class III)
reactions is increasing with age, while cardioinhibitory reactions
upon head-up tilt become less frequent with ageing [25,37,38].
Thus, older patients with neurally mediated syncope may be even
less likely to experience a therapeutic benefit.
The heart rate increase with upright posture decreases with age
[39,40]. In our study, heart rate before the onset of (pre)syncope
was also highest in the youngest quartile and decreased with age.
Moreover, the rate of heart rate decline during (pre)syncope was
blunted with increasing age. These observations suggest cardiac
autonomic regulation deteriorates with age. Consistent with earlier
studies [41,42], the percentage of differences between successive
RR intervals greater than 50 ms (pNN50) - a measure of cardiac
vagal outflow [43] - at rest decreased progressively with age. The
decrease in cardiovagal function with ageing could protect from
excessive vagal cardioinhibition, thus reducing the proportion of
cardioinhibitory responses with or without asystole. Indeed, direct
vagal stimulation can provoke asystole in human subjects [44,45].
Even though cardioinhibitory responses decrease with advancing
age, orthostatic tolerance was virtually identical among age
groups.
Clinical implications
We observed that the decrease in blood pressure preceded the
decrease in heart rate during (pre)syncope in the vast majority of
patients, even in those with cardioinhibitory syncope according
to the modified VASIS classification. Furthermore, our findings
Figure 5. Occurrence of cardioinhibitory responses with
asystole (VASIS IIb) for age quartiles. Asystole became progres-
sively rarer with increasing age (p,.05).
doi:10.1371/journal.pone.0026489.g005
Table 4. Hemodynamics at rest and upon (pre)syncope - age quartiles.
1. Quartile 2. Quartile 3.Quartile 4. Quartile
n =43 n=44 n=44 n=42
Unit Mean±SEM Mean±SEM Mean±SEM Mean±SEM p
at supine rest
Systolic blood pressure [mmHg] 12163 12463 12163 13063 ns
Diastolic blood pressure [mmHg] 6962 7162 7061 7362 ns
Heart rate [bpm] 6662 7062 6661 6362 ,.05
pNN50 [%] 3363 2062 1162 862 ,.001
before and at (pre)syncope
Onset of BP decrease before (pre)syncope [sec] 8669 103610 120612 155615 ,.001
MAP before onset of BP decrease [mmHg] 9963 10162 10863 9963 ns
HR before onset of BP decrease [bpm] 12463 11964 10563 9663 ,.001
Onset of HR decrease before (pre)syncope [sec] 3263 4163 5968 59610 ,.01
MAP before onset of HR decrease [mmHg] 8463 9063 9663 8263 ,.05
HR before onset of HR decrease [bpm] 13063 12264 10763 10064 ,.001
MAP at (pre)syncope [mmHg] 5863 6163 6763 6363 ns
HR at (pre)syncope [bpm] 8467 8867 8164 7965 ns
DMAP before (pre)syncope [mmHg/sec] 20.760.1 20.660.1 20.560.1 20.360.1 ,.001
DHR before (pre)syncope [bpm/sec] 20.560.1 20.460.1 20.260.1 20.160.1 ,.001
Modified VASIS class p
I [n (%)] 26 (60%) 27 (61%) 36 (82%) 20 (48%) ,.05
IIa [n (%)] 1 (2%) 1 (2%) 0 (0%) 1 (2%) ns#
IIb [n (%)] 6 (14%) 4 (9%) 1 (2%) 0 (0%) ,.05
III [n (%)] 10 (23%) 12 (27%) 7 (16%) 21 (50%) ,.01
Statistical significance of differences in continuous and categorical data between age quartiles was tested by ANOVA for multiple comparisons with Bonferroni post test
and chi square test, respectively. HUT = head-up tilt.
#=p,.05 for modified VASIS classes IIa and IIb combined.
Modified VASIS class: I =mixed, IIa = cardioinhibitory without asystole, IIb = cardioinhibitory with asystole, III = vasodepressor.
doi:10.1371/journal.pone.0026489.t004
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challenge utility of the modified VASIS classification which is
ambivalent in that it requires asystole of more than 3 sec duration
and heart rate reduction coinciding or preceding the fall in blood
pressure to account for a cardioinhibitory type IIb. As suggested
by Sir Thomas Lewis, a decrease in blood pressure rather than a
decrease in heart rate initiates the hemodynamic reaction
ultimately leading to neurally mediated syncope [8]. One
implication of our study is that discontinuous blood pressure
monitoring could lead to false diagnostic conclusions. The false
diagnosis of cardioinhibitory syncope, which implies that brady-
cardia precedes hypotension, could then result in unnecessary
pacemaker implantations even in the setting of treatment
guidelines that state otherwise. Our finding of a clear age-
dependency in the occurrence of cardioinhibitory syncope with
asystole (VASIS IIb) has possible therapeutic implications for
documented episodes of asystole (e.g. during EKG loop record-
ings): In young individuals asystole frequently occurs during
neurally-mediated syncope, representing a transient dysfunction
not requiring pacemaker implantation. Conversely, a finding of
asystole in patients older than 60 years is unlikely to be explained
by neurally-mediated syncope but may rather suggest a structural
cardiac disorder.
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